The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
2 marketed package NDCs · 1 active manufacturer
Most dispensed: 12 mg/.6mL · Injection, Solution · #1 blister pack/carton / 1 syringe in 1 blister pack / .6 ml in 1 syringe · 12 mg/.6mL · Injection, Solution · #1 vial, single-dose/carton / .6 ml in 1 vial, single-dose · 8 mg/.4mL · Injection, Solution · #7 blister packs/carton / 1 syringe in 1 blister pack / .4 ml in 1 syringe · 12 mg/.6mL · Injection, Solution · #7 blister packs/carton / 1 syringe in 1 blister pack / .6 ml in 1 syringe
Only one company currently supplies this market — there is no backup if it stumbles.
Other molecules FDA puts in Opioid Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.